Clinical effects of biocompatible dialysis fluids

J Nephrol. 2013 Nov-Dec:26 Suppl 21:76-82. doi: 10.5301/JN.2013.11634. Epub 2013 Nov 28.
No abstract available

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Biomarkers / analysis
  • Biopsy
  • CA-125 Antigen / analysis
  • Dialysis Solutions* / adverse effects
  • Dialysis Solutions* / chemistry
  • Dialysis Solutions* / pharmacokinetics
  • Humans
  • Interleukin-6 / analysis
  • Kidney / physiopathology
  • Membrane Proteins / analysis
  • Pain / etiology
  • Peritoneal Dialysis
  • Peritoneum / drug effects*
  • Peritoneum / metabolism
  • Peritoneum / pathology
  • Peritonitis / etiology
  • Peritonitis / prevention & control
  • Renal Dialysis
  • Vascular Endothelial Growth Factor A / analysis

Substances

  • Biomarkers
  • CA-125 Antigen
  • Dialysis Solutions
  • Interleukin-6
  • MUC16 protein, human
  • Membrane Proteins
  • Vascular Endothelial Growth Factor A